Ramadhan Abdullah, Troug Anita, Yacyshyn Elaine, Gniadecki Robert
Department of Dermatology, University of Alberta, Edmonton, AB, Canada.
SAGE Open Med Case Rep. 2025 Jun 29;13:2050313X251350376. doi: 10.1177/2050313X251350376. eCollection 2025.
A 61-year-old female with systemic lupus erythematosus presented with refractory discoid lupus. Despite treatment with numerous immunosuppressive therapies, including prednisone, hydroxychloroquine and mycophenolate mofetil, her cutaneous lupus remained active and significantly impacted her quality of life. Introduction of anifrolumab led to remarkable improvement, highlighting its potential for refractory discoid lupus erythematosus.
一名61岁的系统性红斑狼疮女性患者出现难治性盘状狼疮。尽管接受了包括泼尼松、羟氯喹和霉酚酸酯在内的多种免疫抑制治疗,但其皮肤狼疮仍处于活动状态,严重影响了她的生活质量。阿尼鲁单抗的引入带来了显著改善,凸显了其在难治性盘状红斑狼疮中的潜力。